Clinical immunology<BR>Periodontal disease and cytokine inhibitors

Sylwia Małgorzata Słotwińska; Robert Słotwiński

eISSN: 1644-4124
ISSN: 1426-3912

Central European Journal of Immunology

Current issue Subscription

Editorial System

Submit your Manuscript

1-2/2006
vol. 31

Send email

Copy url:

abstract:

Clinical immunology
Periodontal disease and cytokine inhibitors

Sylwia Małgorzata Słotwińska

,

Robert Słotwiński

(Centr Eur J Immunol 2006; 31 (1-2): 22-24)

Online publish date: 2006/10/12

View full text Get citation

The aim of the presented paper was to examine the occurrence in saliva of interleukin – 1 receptor antagonist (IL-1 ra) and soluble receptor type I of tumor necrosis factor (sTNF RI) in patients with periodontitis. The levels of interleukin-1 receptor antagonist and soluble TNF receptor type I (s TNF RI, p55) in saliva were determined with an immunoenzymatic ELISA method using a factory-ready quantitative enzymatic test manufactured by Quantikine, R&D System. The level of occurrence for interleukin-1 receptor antagonist (IL-1 ra) in saliva was statistically significantly higher (p<0.05) in persons with periodontitis as compared with the control group.

keywords:

Clinical immunologyPeriodontal disease and cytokine inhibitors

Sylwia Małgorzata Słotwińska , Robert Słotwiński

periodontal disease, interleukin – 1 receptor antagonist (IL-1 ra), soluble receptor type I of tumor necrosis factor (sTNF RI)

Clinical immunology
Periodontal disease and cytokine inhibitors

Sylwia Małgorzata Słotwińska

,

Robert Słotwiński